Literature DB >> 11251537

Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes.

J J Cartledge1, I Eardley, J F Morrison.   

Abstract

OBJECTIVE: To determine if advanced glycation end-products (AGEs) are responsible for the lower neuronal and endothelial-derived nitric oxide (NO)-mediated relaxation of corpus cavernosum in tissue in diabetic rats than in control rats.
MATERIALS AND METHODS: Diabetes was induced in male Wistar rats by an intraperitoneal injection with streptozotocin (60 mg/kg). One group of diabetic rats was given free access to water and standard diet. A second group was given standard diet and aminoguanidine with their water (50 mg/100 mL) from the initiation of diabetes. Two groups of rats that were not diabetic acted as age-matched controls. After 8 weeks animals were killed by cervical dislocation, corpus cavernosal tissue strips harvested and mounted in an organ bath to measure isometric tension. After 90 min of equilibration at optimal resting tension and contraction with 1 micromol/L noradrenaline, the response to either acetylcholine or electrical field stimulation (EFS) after adding guanethidine (5 micromol/L) and atropine (1 micromol/L) was determined for each group.
RESULTS: There was no difference between the baseline characteristics of all the experimental groups. After 8 weeks the mean body mass and glycosylated haemoglobin (HbA1c) were significantly greater in the diabetic than in control animals. Aminoguanidine had no effect on the recorded body mass or HbA1c. The in vitro relaxation response to the application of acetylcholine or EFS of tissue strips from age-matched control animals fed a standard diet and those supplemented with aminoguanidine were the same. The administration of aminoguanidine to diabetic animals for 8 weeks reversed the expected impaired relaxation response to acetylcholine; the response to EFS was similar.
CONCLUSION: AGEs are more prevalent in erectile tissue from diabetic than in control animals. Aminoguanidine reversed the impairment in neuronal and endothelial NO-mediated penile smooth muscle relaxation seen in diabetes. As aminoguanidine prevents AGE formation, erectile dysfunction in diabetes is probably caused partly by the generation of AGEs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11251537     DOI: 10.1046/j.1464-410x.2001.00067.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  13 in total

1.  Effects of prolonged ingestion of epigallocatechin gallate on diabetes type 1-induced vascular modifications in the erectile tissue of rats.

Authors:  C Lombo; C Morgado; I Tavares; D Neves
Journal:  Int J Impot Res       Date:  2016-05-12       Impact factor: 2.896

2.  Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction.

Authors:  Biljana Musicki; Melissa F Kramer; Robyn E Becker; Arthur L Burnett
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-05       Impact factor: 11.205

3.  The molecular basis of erectile dysfunction: from bench to bedside.

Authors:  Jesse N Mills; Albaha Barqawi; Sweaty Koul; Hari Koul; Randall B Meacham
Journal:  Rev Urol       Date:  2005

4.  Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes.

Authors:  Hunter Wessells; David F Penson; Patricia Cleary; Brandy N Rutledge; John M Lachin; Kevin T McVary; David S Schade; Aruna V Sarma
Journal:  J Urol       Date:  2011-03-21       Impact factor: 7.450

5.  Molecular targets for diabetes mellitus-associated erectile dysfunction.

Authors:  Elizabeth Yohannes; Jinsook Chang; Moses T Tar; Kelvin P Davies; Mark R Chance
Journal:  Mol Cell Proteomics       Date:  2009-12-10       Impact factor: 5.911

Review 6.  Management of erectile dysfunction in diabetes: an update for 2008.

Authors:  David Price; Geoffrey Hackett
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

Review 7.  Causes of erectile dysfunction.

Authors:  Jeremy P W Heaton; Michael A Adams
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

8.  Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes.

Authors:  S Cellek; W Qu; A M Schmidt; S Moncada
Journal:  Diabetologia       Date:  2003-12-16       Impact factor: 10.122

Review 9.  A comprehensive review of urologic complications in patients with diabetes.

Authors:  Fernando Arrellano-Valdez; Marta Urrutia-Osorio; Carlos Arroyo; Elena Soto-Vega
Journal:  Springerplus       Date:  2014-09-23

10.  Constitutive LH receptor activity impairs NO-mediated penile smooth muscle relaxation.

Authors:  Deepak S Hiremath; Fernanda B M Priviero; R Clinton Webb; CheMyong Ko; Prema Narayan
Journal:  Reproduction       Date:  2021-01       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.